Version history

1 version on record. Newest first; the live version sits at the top with a live indicator.

  1. Live
    4/21/2026, 5:00:14 AM
    Content snapshot
    {
      "session_id": "sess_SDA-BIOMNI-SPATIAL_-c2b61633",
      "round_number": 1,
      "agent_persona": "persona-theorist",
      "agent_backend": "mini-max",
      "action": "propose",
      "content": "\n\n# Spatial Gene Expression Hypotheses: AD Pathology Staging in Hippocampus-Entorhinal Circuit\n\n---\n\n## Hypothesis 1: Entorhinal Layer II Stellate Cell Vulnerability as Stage-Signature\n\n**Title:** Entorhinal cortical layer II spatial neighborhoods show earliest transcriptional dysregulation in AD progression\n\n**Description:** Spatial transcriptomics will reveal that Layer II stellate cells in the entorhinal cortex (EC LII) exhibit the earliest gene expression changes, specifically downregulating mitochondrial oxidative phosphorylation genes (MT-CO1, MT-CO3) and synaptic machinery genes (SNPH, SYT1) before amyloid plaque deposition in adjacent layers. This vulnerability stems from their unique position as primary recipients of olfactory-cortical input and their involvement in grid cell generation, making them particularly sensitive to bioenergetic stress.\n\n**Target Gene/Protein:** MT-CO1 (mitochondrial complex IV), SNAP25,Synaptophysin\n\n**Confidence Score:** 0.78\n\n---\n\n## Hypothesis 2: Dentate Gyrus-Granule Cell Layer Microenvironment Predicts Rapid Progression\n\n**Title:** Dentate gyrus molecular signature loss predicts transition from early to intermediate AD pathology\n\n**Description:** Spatial neighborhoods within the dentate gyrus granule cell layer (DG GCL) showing early loss of *Calb1* (calbindin) and *Pcna* (proliferation marker) expression will strongly predict rapid progression to Braak stages III-IV. The DG is particularly sensitive to reduced neurogenesis and input disruption; loss of its molecular signature indicates circuit-level failure in pattern separation that precedes broader hippocampal dysfunction.\n\n**Target Gene/Protein:** Calbindin D-28k (CALB1), Doublecortin (DCX)\n\n**Confidence Score:** 0.72\n\n---\n\n## Hypothesis 3: TREM2+ Microglial Spatial Clustering Predicts Regional Tau Spread\n\n**Title:** TREM2-positive microglial spatial neighborhoods at EC-hippocampus interface predict tau propagation trajectory\n\n**Description:** Disease-associated microglia (DAM) clustering defined by *TREM2*, *CLEC7A*, and *LPL* expression will form spatially restricted \"inflammatory neighborhoods\" at EC-hippocampus interfaces that correlate with initial tau deposition patterns. These microglial clusters will preferentially form near blood vessels and myelin-rich regions, facilitating Aβ-mediated tau seeding. Genes like *TYROBP* (DAP12) co-expression will indicate productive phagocytic versus dysfunctional states.\n\n**Target Gene/Protein:** TREM2, CLEC7A, LPL, TYROBP\n\n**Confidence Score:** 0.82\n\n---\n\n## Hypothesis 4: CA1-Subiculum Transition Zone Gene Expression Distinguishes Braak Stages\n\n**Title:** CA1-subiculum border zone transcriptional signature discriminates advanced AD stages\n\n**Description:** The CA1-subiculum border zone (\"prosubiculum\") will show distinct gene expression patterns that specifically distinguish early (I-II) from intermediate (III-IV) pathology: upregulated *GFAP* astrocyte reactivity and downregulated *Wfs1* (Wolfram syndrome 1) specifically mark transition to intermediate stages. This border is anatomically positioned to gate output to the subiculum and is highly vulnerable to tau pathology spreading from the EC through Schaffer collaterals.\n\n**Target Gene/Protein:** GFAP, WFS1, PPP3CA (calcineurin A)\n\n**Confidence Score:** 0.69\n\n---\n\n## Synthesis\n\n| Hypothesis | Primary Region | Predictive Power | Mechanistic Basis |\n|------------|----------------|------------------|-------------------|\n| H1 | EC Layer II | Earliest diagnostic signal | Bioenergetic/mitochondrial |\n| H2 | DG GCL | Progression velocity | Neurogenesis failure |\n| H3 | EC-Hip Interface | Tau spread trajectory | Microglial-mediated |\n| H4 | CA1-Subiculum | Stage discrimination | Synaptic/circuit failure |\n\n**Recommended Priority:** H3 (highest confidence, therapeutic relevance via TREM2 pathway); H1 (earliest diagnostic window).",
      "tokens_used": "970"
    }